4//SEC Filing
Nicacio Leonardo Viana 4
Accession 0001213900-25-032965
CIK 0001359931other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:10 PM ET
Size
7.6 KB
Accession
0001213900-25-032965
Insider Transaction Report
Form 4
Nicacio Leonardo Viana
Chief Medical Officer
Transactions
- Award
Common Stock
2025-04-15+50,000→ 52,181 total - Award
Stock Option (Right to Buy)
2025-04-15+150,000→ 150,000 totalExercise: $4.17Exp: 2035-04-14→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of April 15, 2025.
- [F2]25% of the shares vest on the one year anniversary of April 15, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0002064901
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:10 PM ET
- Size
- 7.6 KB